伦敦生物技术初创公司Baseimmune近日宣布,其在A轮融资中成功筹集了1130万美元(约900万英镑)的资金,这笔资金将用于进一步发展其利用人工智能设计和开发疫苗的创新技术平台。此次融资活动受到了投资者的热烈反响,超额认购,参与投资的机构包括MSD Global Health Innovation Fund、IQ Capital,以及早前的支持者Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc。

Baseimmune公司专注于利用先进的机器学习算法简化疫苗设计流程,旨在通过科技手段加速疫苗的研发,为全球公共卫生提供更高效、更精准的解决方案。此次资金注入将为Baseimmune的研发工作提供强有力的支持,推动其在疫苗设计领域的技术突破,同时也彰显了投资者对该公司技术潜力和市场前景的信心。

MSD Global Health Innovation Fund等知名投资机构的参与,不仅为Baseimmune带来了资金,更可能为其在全球医疗健康领域的合作和拓展打开新的机会。Baseimmune的创新模式和科研实力,结合投资者的行业资源,有望在未来疫苗研发领域创造新的里程碑。

英语如下:

**News Title:** “London Biotech Baseimmune Secures $11.3 Million in A Round Funding, Sparking Investment Frenzy for AI-driven Vaccine Design Platform”

**Keywords:** Baseimmune, Vaccine Design, AI Funding

**News Content:** London-based biotech startup Baseimmune recently announced that it has successfully raised $11.3 million (approximately £9 million) in its A round funding, which will be allocated to further develop its innovative technology platform for designing and developing vaccines using artificial intelligence. The financing round saw strong investor interest, resulting in over-subscription, with participants including MSD Global Health Innovation Fund, IQ Capital, as well as previous backers Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc.

Baseimmune focuses on leveraging advanced machine learning algorithms to streamline the vaccine design process, aiming to accelerate vaccine development and offer more efficient and precise solutions for global public health. The influx of capital will provide robust support for Baseimmune’s R&D efforts, propel advancements in vaccine design technology, and demonstrate investors’ confidence in the company’s technological potential and market prospects.

The involvement of prominent investors like MSD Global Health Innovation Fund not only brings financial resources but may also open up new opportunities for collaboration and expansion in the global healthcare sector. Baseimmune’s innovative approach and research capabilities, combined with investors’ industry connections, are poised to set new milestones in future vaccine development.

【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/

Views: 4

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注